FTSE All-Share

FTSE All-Share handeln
5.536,97 PKT +57,19 PKT +1,04 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
25.09.20 Barclays overweight JP Morgan Chase & Co.
25.09.20 Lloyds Banking Group Neutral JP Morgan Chase & Co.
25.09.20 Vodafone Group buy Jefferies & Company Inc.
24.09.20 Rio Tinto Equal-Weight Morgan Stanley
22.09.20 Lloyds Banking Group buy UBS AG
22.09.20 HSBC Neutral UBS AG
22.09.20 Barclays buy UBS AG
22.09.20 Unilever buy Jefferies & Company Inc.
22.09.20 Unilever buy Jefferies & Company Inc.
22.09.20 BAT Outperform RBC Capital Markets
22.09.20 GSK Neutral JP Morgan Chase & Co.
22.09.20 Prudential Sector Perform RBC Capital Markets
18.09.20 AstraZeneca overweight JP Morgan Chase & Co.
17.09.20 BP Conviction Buy List Goldman Sachs Group Inc.
17.09.20 BP overweight JP Morgan Chase & Co.
17.09.20 BP Underperform RBC Capital Markets
16.09.20 Vodafone Group buy Goldman Sachs Group Inc.
15.09.20 BP buy UBS AG
15.09.20 Glencore Outperform RBC Capital Markets
15.09.20 BP Underperform RBC Capital Markets
15.09.20 Rio Tinto Equal weight Barclays Capital
15.09.20 Rio Tinto overweight JP Morgan Chase & Co.
14.09.20 Rio Tinto Neutral UBS AG
14.09.20 Shell (ex Royal Dutch Shell) Outperform Credit Suisse Group
14.09.20 BP Outperform Credit Suisse Group
11.09.20 Rio Tinto Neutral JP Morgan Chase & Co.
11.09.20 Rio Tinto buy Jefferies & Company Inc.
11.09.20 Rio Tinto Sector Perform RBC Capital Markets
11.09.20 BP overweight Barclays Capital
11.09.20 Lloyds Banking Group Sell Goldman Sachs Group Inc.
10.09.20 Rio Tinto Underperform Credit Suisse Group
10.09.20 BP buy UBS AG
10.09.20 London Stock Exchange (LSE) overweight JP Morgan Chase & Co.
10.09.20 AstraZeneca overweight JP Morgan Chase & Co.
09.09.20 Shell (ex Royal Dutch Shell) Outperform RBC Capital Markets
09.09.20 BP buy Kepler Cheuvreux
09.09.20 AstraZeneca Sell UBS AG
09.09.20 London Stock Exchange (LSE) Neutral UBS AG
09.09.20 AstraZeneca Hold Jefferies & Company Inc.
09.09.20 AstraZeneca Sell Goldman Sachs Group Inc.